The treatment has the potential to cure diseases, but high costs and a difficult delivery process have held it back.
Roche Holding AG is willing to pay more than $1 billion to solve one ...
New strategic partnership leverages the power of the Dyno platform, enabling Roche to advance next-generation AAV gene therapies across multiple targets
Dyno to receive US$50 million upfront cash ...
The Beacon for CRISPR Cures aims to create a roadmap for rapidly developing genome-editing therapies.
The story of CRISPR in medicine so far has been one of remarkable speed. It ...
Concert Health, a leading behavioral health medical group, today announced results from a program with Mercy Health, one of the largest U.S. healthcare systems. The partnership provided Mercy Health’s ...
CRISPR pioneer Jennifer Doudna's company Scribe Therapeutics inked a major deal with Prevail Therapeutics potentially worth $1.5 billion to create genetic medicines for neurological and neuromuscular diseases. Scribe CEO ...
Scribe Therapeutics found another partner, this time with Prevail Therapeutics, a subsidiary of Eli Lilly, in a $75 million upfront deal for neuromuscular and neurological diseases.
Unlike Scribe’s ex vivo ...
Collaboration combines Scribe Therapeutics’ novel CRISPR by Design™ approach with Prevail Therapeutics’ deep expertise in developing genetic medicines for neurological disorders towards specified genetic targets
Scribe to receive ...
Sanofi has teamed up with Scribe Therapeutics to write the next chapter in its natural killer (NK) cell therapy story, paying $25 million upfront and committing to $1 billion ...
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe’s CRISPR ...
Memora Health, the leading technology platform for virtual care delivery and complex care management, today announced a partnership with UP Medical, a multi-specialty medical group, dedicated to raising standards ...
Concert Health has inked two new collaborative care partnerships — one with Benson Hospital, a rural health hospital in Arizona, and another with Women’s Health U.S. (WHUSA), a multi-state ...
Behavioral health is having a moment — and rightfully so. Four in 10 adults in the U.S. reported having symptoms of anxiety or depression during our pandemic year, up ...
A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a platform designed ...
Three years ago, Jennifer Doudna gathered with two postdocs and a fellow biochemist around a circular table on the second floor of UC Berkeley’s Energy Biosciences building, where they ...
The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for ...
Pioneers in the field of gene-editing technology will collaborate with one of the world's biggest drugmakers on accelerating the search for new medicines using the promising tool known as ...
GlaxoSmithKline is launching a rare partnership with an American university through which the UK drugmaker will fund more than 20 scientists at a new laboratory focused on human genome ...
When Hal Barron unveiled his grand plan to turn GlaxoSmithKline’s R&D group around, he championed genetics as one of two key focuses for the UK pharma giant, announcing a ...
GlaxoSmithKline is joining forces with the University of California to dig into how gene mutations cause disease and to use CRISPR to discover new drugs. The partners will set up a ...
Drug company GlaxoSmithKline announced today that it will establish a laboratory for CRISPR technologies as part of a five-year collaboration with University of California researchers.
The new Laboratory for Genomics ...
GlaxoSmithKline’s latest move to reinvigorate R&D is a collaboration with two of the biggest names in CRISPR research to develop new gene editing technologies and use them to identify ...
The University of California announced a major deal Thursday with the drug company GlaxoSmithKline, in which the pharmaceutical firm will provide up to $67 million over five years to ...
Top CRISPR researchers at two University of California (UC) campuses have teamed up with pharmaceutical giant GlaxoSmithKline (GSK) to form a new laboratory in San Francisco that will exploit the ...
The pharmaceutical company GlaxoSmithKline (GSK) today announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will be used to explore how ...
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome
Issued: London and San Francisco - GlaxoSmithKline plc today announced a ...
SilvaClean and CLS deliver 99.9% infection control with cost savings to Northern California healthcare facilities.
HAYWARD, Calif., June 2, 2016 - Applied Silver, the maker of SilvaClean®, today announced a ...
